SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-162132
Filing Date
2015-04-30
Accepted
2015-04-30 16:30:44
Documents
5
Period of Report
2015-06-11
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d874681ddef14a.htm DEF 14A 517566
2 GRAPHIC g874681g11e59.jpg GRAPHIC 78992
3 GRAPHIC g874681g29h98.jpg GRAPHIC 22894
4 GRAPHIC g874681g75r60.jpg GRAPHIC 85076
5 GRAPHIC g874681g86t46.jpg GRAPHIC 5596
  Complete submission text file 0001193125-15-162132.txt   784514
Mailing Address 2525 28TH STREET SUITE 100 BOULDER CO 80301
Business Address 2525 28TH STREET SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35347 | Film No.: 15819189
SIC: 2834 Pharmaceutical Preparations